Patients with implantable left ventricular assist devices (LVAD) are at risk of ventricular arrhythmias but these may be hemodynamically tolerated. An electrocardiogram (ECG) is essential to determine whether an LVAD-supported patient is experiencing a ventricular arrhythmia. Access to 12 lead ECG is predominantly in healthcare facilities. Implantable LVAD also cause significant electromagnetic interference leading to artefacts on ECG. We report a patient on Heartmate 3 LVAD with a diagnostic quality 6 lead ECG obtained with an AliveCor device during an episode of sustained palpitations. The AliveCor device may be used for remote identification of ventricular arrhythmias in LVAD patients.
MehraMRUrielNNakaY, et al.; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device – final report. N Engl J Med2019; 380(17): 1618–1627.
2.
PettitSJPetrieMCConnellyDT, et al. Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. Eur J Heart Fail2012; 14(7): 696–702.
3.
GordonJSMaynesEJChoiJH, et al. Ventricular arrhythmias following continuous-flow left ventricular assist device implantation: a systematic review. Artif Organs2020; 44(8): E313–E325.
4.
DoğanÖArslanŞÖzyıldırımS, et al. A stable patient with a left ventricular assist device was admitted to the outpatient clinic with ventricular fibrillation. Anatol J Cardiol2021; 25(8): 595–597.
5.
SmithMEMoakJH. Asymptomatic ventricular fibrillation in continuous flow leftventricular assist device. Am J Emerg Med2021; 49: 130–132.
6.
WatanakeereeKSubaSMackinLA, et al. ECG alarms during left ventricular assist device (LVAD) therapy in the ICU. Heart Lung2021; 50(6): 763–769.
7.
JunartaJFrischDRDikdanS, et al. Expanding a single-lead mobile electrocardiographic device to multiple-lead recordings improves diagnostic accuracy and confidence. J Electrocardiol2021; 67: 77–83.
8.
JohnsonDMJunartaJGeraceC, et al. Usefulness of mobile electrocardiographic devices to reduce urgent healthcare visits. Am J Cardiol2021; 153: 125–128.
9.
LiuHHEzekowitzMDColumboM, et al. Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic. J Interv Card Electrophysiol2022; 63(2): 345–356.
10.
LoringZSenSBlack-MaierE, et al. Reducing ECG artifact from left ventricular assist device electromagnetic interference. J Am Heart Assoc2020; 9(16): e017563.
11.
MercerBLeeseLAhmedN, et al. A simple adaptation of a handheld ECG recorder to obtain chest lead equivalents. J Electrocardiol2020; 63: 54–56.
